Germany’s new ZB MED is “about ensuring that a single fragile pipeline doesn’t bottleneck good science,” experts write.
The ability to follow patients with this high sensitivity allows us to make a more accurate and precise measurement, and we can see small changes or see them in a shorter period of time…,” ...